Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Saude-Conde R"'
Autor:
Haugaard AK; Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Saude Conde R; Digestive Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Brussels, Belgium., J Maria AR; Comprehensive Health Research Centre, Nova Medical School | Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisbon, Portugal., Vithal Yergolkar A; Naperville, Illinois, USA., Jørgensen KJ; Cochrane Denmark and Centre for Evidence Based Medicine Odense, University of Southern Denmark, Odense, Denmark., Heleno B; Comprehensive Health Research Centre, Nova Medical School | Faculdade de Ciências Médicas da Universidade NOVA de Lisboa, Lisbon, Portugal.
Publikováno v:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Sep 18; Vol. 9. Cochrane AN: CD014720. Date of Electronic Publication: 2024 Sep 18.
Autor:
Assaf I; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Fimereli D; Breast Cancer Translational Laboratory, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Anthoine G; GI Cancer Laboratory, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Fazio R; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Daprà V; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Audisio A; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Bardiaux A; GI Cancer Laboratory, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Telli TA; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Vanhooren M; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Saude-Conde R; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium., Bregni G; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium.; Medical Oncology, Faculty of Medecine, Erasmus Campus, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium., Hendlisz A; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium.; Medical Oncology, Faculty of Medecine, Erasmus Campus, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium., Sclafani F; Department of Digestive Oncology, Institut Jules Bordet, The Brussels University Hospital, 1070 Brussels, Belgium.; Medical Oncology, Faculty of Medecine, Erasmus Campus, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 13; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 13.
Autor:
Saúde-Conde, R., Vandamme, T., De Backer, M., Martinive, P., Covas, A., Deleporte, A., Dermine, A., Forget, F., Geboes, K., Gilliaux, Q., Gokburun, Y., Gonne, E., Joye, I., Lecomte, S., Liberale, G., Lybaert, W., Moretti, L., Mortier, L., Mupingu Mwanawa, S., Puleo, F., Saad, E.D., Sinapi, I., Annemans, L., Buyse, M., Sclafani, F.
Publikováno v:
In ESMO Gastrointestinal Oncology June 2024 4
Publikováno v:
In Pulmonology March-April 2021 27(2):177-180
Autor:
Akin Telli T; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium., Bregni G; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium., Vanhooren M; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium., Saude Conde R; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium., Hendlisz A; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium., Sclafani F; Department of Gastrointestinal Oncology, Institut Jules Bordet, Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: francesco.sclafani@bordet.be.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2022 Nov; Vol. 110, pp. 102460. Date of Electronic Publication: 2022 Aug 27.
Autor:
Saude Conde R; Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium., Bregni G; Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium., Saad E; Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium., Hendlisz A; Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium., Sclafani F; Rita Saude Conde, MD, Institut Jules Bordet, Brussels, Belgium; Giacomo Bregni, MD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium; Everardo Saad, MD, International Drug Development Institute, Louvain-la-Neuve, Belgium, Dendrix Research, Sao Paulo, Brazil; and Alain Hendlisz, MD, PhD, and Francesco Sclafani, MD, PhD, Institut Jules Bordet, Brussels, Belgium, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Mar 01; Vol. 40 (7), pp. 803-805. Date of Electronic Publication: 2022 Jan 13.
Autor:
Jung Suk Kim1, Seunghyun Cheon1, Mi Ran Woo1, Sanghyun Woo1, Jee-Eun Chung1, Yu Seok Youn2, Kyung Taek Oh3, Soo-Jeong Lim4, Sae Kwang Ku5, Bao Loc Nguyen6, Jong Oh Kim6 jongohkim@yu.ac.kr, Sung Giu Jin7 sklover777@dankook.ac.kr, Han-Gon Choi1 hangon@hanyang.ac.kr
Publikováno v:
Asian Journal of Pharmaceutical Sciences. Oct2024, Vol. 19 Issue 5, p1-13. 13p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.